Citation:Milla M,P D. Pi?ero.Characterization, passive and active treatment in strabismic amblyopia: a narrative review.Int J Ophthalmol 2020;13(7):1132-1147,doi:10.18240/ijo.2020.07.18
Characterization, passive and active treatment in strabismic amblyopia: a narrative review
Received:August 23, 2019  Revised:March 15, 2020
Email this Article  Add to Favorites  Print
DOI:10.18240/ijo.2020.07.18
Key Words:amblyopia  strabismus  occlusion  vision therapy  strabismic amblyopia  penalization  Bangerter foil
Fund Project:Supported by the Ministry of Economy, Industry and Competitiveness of Spain within the program Ramón y Cajal (RYC-2016-20471).
     
AuthorInstitution
Myriam Milla Department of Optometry, OFTALVIST Alicante, Alicante 03016, Spain; Group of Optics and Visual Perception, Department of Optics, Pharmacology and Anatomy, University of Alicante, San Vicente del Raspeig, Alicante 03690, Spain
David P. Pi?ero Group of Optics and Visual Perception, Department of Optics, Pharmacology and Anatomy, University of Alicante, San Vicente del Raspeig, Alicante 03690, Spain
Hits: 358
Download times: 48
Abstract:
      Strabismic amblyopia is characterized by a distorted spatial perception. In this condition, the neurofunctional disorder occurring during first years of life provoke several monocular and binocular anomalies such as crowding, deficits in the accommodative response, contrast sensitivity, and ocular motility abilities. The inhibition of the binocular function of the brain by the misaligned amblyopic eye induces a binocular imbalance leading to interocular suppression and the reduction or lack of stereoacuity. Passive treatments such as occlusion, optical and/or pharmacological penalization, and Bangerter foils has been demonstrated to be potentially useful treatments for strabismic amblyopia. Recent researches have proved new pharmacological options to improve and maintain visual acuity after occlusion treatment in strabismic amblyopia. Likewise, the active vision therapy, in the last years, is becoming a very relevant therapeutic option in combination with passive treatments, especially during and after monocular therapy, in the attempt of recovering the imbalanced binocular vision.
PMC FullText Html:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321947/
Supplementary Material
PDF Fulltext  Download reader  HTML Fulltext   View/Add Comment